Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0CP3M
|
||||
| Former ID |
DNC014860
|
||||
| Drug Name |
4,5,6,7-tetrabromo-1H-benzimidazole
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529933] | ||
| Formula |
C7H2Br4N2
|
||||
| Canonical SMILES |
C1=NC2=C(N1)C(=C(C(=C2Br)Br)Br)Br
|
||||
| InChI |
1S/C7H2Br4N2/c8-2-3(9)5(11)7-6(4(2)10)12-1-13-7/h1H,(H,12,13)
|
||||
| InChIKey |
LOEIRDBRYBHAJB-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Casein kinase II, alpha chain | Target Info | Inhibitor | [529933] | |
| NetPath Pathway | FSH Signaling Pathway | ||||
| Pathway Interaction Database | BCR signaling pathway | ||||
| Atypical NF-kappaB pathway | |||||
| DNA-PK pathway in nonhomologous end joining | |||||
| Presenilin action in Notch and Wnt signaling | |||||
| Role of Calcineurin-dependent NFAT signaling in lymphocytes | |||||
| E-cadherin signaling in the nascent adherens junction | |||||
| Lissencephaly gene (LIS1) in neuronal migration and development | |||||
| PDGFR-alpha signaling pathway | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| Alpha-synuclein signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.